Assessing kidney function using electrical impedance tomography
Official title: Assessment of Kidney Function by Self-administrable and Portable Electrical Impedance Tomography (EIT)
Run by The University of Hong Kong · NCT06898294 · Data updated 2026-11-12
This study is testing a new portable device that uses electrical signals to create images of the kidneys, helping doctors better understand and monitor chronic kidney disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 144 (estimated) |
| Sponsor | The University of Hong Kong Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Hong Kong) |
| Status | Recruiting |
| Started | September 1, 2021 |
| Main results expected | August 31, 2025 |
| Study ends | August 31, 2025 |
| Registry record updated | March 27, 2025 |
| Trial ID | NCT06898294 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals aged 18-90 who have been clinically diagnosed with chronic kidney disease at any stage.
✕Probably not a fit
Patients with known kidney abnormalities, recent kidney surgery, or certain neurological disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates the Gense EIT-kidney device, a portable and non-invasive imaging tool that uses electrical impedance tomography (EIT) to assess kidney function. The device employs a band of 16 electrodes placed around the abdomen to capture bioelectrical impedance data at various frequencies. These measurements are processed to create functional images of the kidneys, aiding in the diagnosis of chronic kidney disease (CKD). The study aims to improve the understanding and monitoring of CKD through advanced imaging techniques.
Why it matters
Potential benefit: If successful, this study could provide a non-invasive method for early detection and monitoring of chronic kidney disease.
How similar studies have gone: While the use of electrical impedance tomography in kidney assessment is relatively novel, similar imaging techniques have shown promise in other areas of medical diagnostics.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- clinically diagnosed with CKD at different stages (stage 1-5) of the disease based on GFR measurement results Age: 18-90. Gender: Male/ Female Exclusion Criteria: * ● Subjects with known kidney disease or abnormalities (for the control group). * Subjects who had any kind of kidney surgery or kidney transplantation. * Subjects with damaged skin on the abdomen. * Subjects with implanted electronic devices. * Subjects with spinal diseases/discomfort * Subjects who had any recent abdominal surgery * Pregnant women. * Obese subjects (BMI\>35). * Subjects with uncontrollable involuntary body movements such as degenerative disorders (e.g., Alzheimer's and Parkinson's disease); Seizure disorders (e.g., epilepsy, stroke, neuroleptic drugs); Neurological disorders (e.g., tardive dyskinesia and cerebral palsy, tremors, myoclonus, tics, athetosis, etc.)
Where it's running
-
Queen Mary Hospital, Hong Kong
Hong Kong, Hong Kong Recruiting
Study contacts
- Principal investigator: Yat Hin, Desmond Yap, PhD, MD — The University of Hong Kong
- Study coordinator: Yat Hin, Desmond Yap, PhD, MD
- Email: desmondy@hku.hk
- Phone: 22554385
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes
This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.
-
Impact of TAVR on kidney function in people with aortic valve disease
This registry tests how trans-catheter aortic valve implantation affects kidney function and the risk of kidney injury in adults with aortic stenosis.
-
Calciphylaxis in people with chronic kidney disease: causes, risks, and early signs
This project will compare adults with chronic kidney disease who develop calciphylaxis to matched CKD patients who do not, collecting clinical data and biological samples to try to find risk factors and early signs.
-
Oral Semaglutide for CKD and MAFLD in adults with diabetes
This study tests whether adding oral semaglutide to standard care can slow kidney and liver disease progression in adults with CKD and MAFLD who have type 2 diabetes.
-
Eye-brain-kidney connections in chronic kidney disease
This study will see if changes in brain network connectivity and retinal blood vessels are linked to cognitive decline and kidney function in adults with chronic kidney disease.
-
Screening for chronic kidney disease
We will see how common chronic kidney disease is among adults followed at a tertiary care center and how many cases were previously undiagnosed.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.